Albers, R, van der Wielen, RP, Brink, EJ, Hendriks, HF, Dorovska-Taran, VN & Mohede, IC (2003) Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 57, 595–603.
Basu, S (1998) Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 347–352.
Basu, S (2003) Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 189, 113–127.
Basu, S, Risérus, U, Turpeinen, A & Vessby, B (2000 a) Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci 99, 511–516.
Basu, S, Smedman, A & Vessby, B (2000 b) Conjugated linoleic acid induces lipid peroxidation in human subjects. FEBS Lett 468, 33–36.
Blankson, H, Stakkestad, JA, Fagertun, H, Thom, E, Wadstein, J & Gudmundsen, O (2000) Conjugated linoleic acid reduces body fat mass in overweight and obese human subjects. J Nutr 130, 2943–2948.
Dichtl, W, Ares, MP, Jonson, AN, Jovinge, S, Pachinger, O, Giachelli, CM, Hamsten, A, Eriksson, P & Nilsson, J (2002) Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism 51, 327–333.
Forouhi, NG, Sattar, N & McKeigue, PM (2001) Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25, 1327–1331.
Grimble, RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5, 551–559.
Grundy, SM (2003) Inflammation, metabolic syndrome, and diet responsiveness. Circulation 108, 126–128.
Hauner, H, Bender, M, Haastert, B & Hube, F (1998) Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 22, 1239–1243.
Hotamisligil, GS, Arner, P, Atkinson, RL & Spiegelman, BM (1997) Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46, 451–455.
Hotamisligil, GS, Arner, P, Caro, JF, Atkinson, RL & Spiegelman, BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95, 2409–2415.
Kelley, DS, Taylor, PC, Rudolph, IL, Benito, P, Nelson, GJ, Mackey, BE & Erickson, KL (2000) Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids 35, 1065–1071.
Kelly, GS (2001) Conjugated linoleic acid: a review. Altern Med Rev 6, 367–382.
Krieglstein, CF & Granger, DN (2001) Adhesion molecules and their role in vascular disease. Am J Hypertens 14, 44S–54S.
Lind, L (2003) Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169, 203–214.
Marui, N, Offermann, MK, Swerlick, R, Kunsch, C, Rosen, CA, Ahmad, M, Alexander, RW & Medford, RM (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92, 1866–1874.
Mohamed-Ali, V, Goodrick, S, Bulmer, K, Holly, JM, Yudkin, JS & Coppack, SW (1999) Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277, E971–E975.
Mougios, V, Matsakasa, A, Petridoua, A, Ringb, S, Sagredosc, A, Melissopouloua, A, Tsigilisa, N & Nikolaidis, M (2001) Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 12, 585–594.
Nilsson, J, Jovinge, S, Niemann, A, Reneland, R & Lithell, H (1998) Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 18, 1199–1202.
Pasceri, V, Willerson, JT & Yeh, ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102, 2165–2168.
Ridker, PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363–369.
Ridker, PM, Buring, JE, Cook, NR & Rifai, N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391–397.
Ridker, PM, Cushman, M, Stampfer, MJ, Tracy, RP & Hennekens, CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336, 973–979.
Risérus, U, Arner, P, Brismar, K & Vessby, B (2002 a) Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25, 1516–1521.
Risérus, U, Basu, S, Jovinge, S, Fredrikson, G, Ärnlöv, J & Vessby, B (2002 b) Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 106, 1925–1929.
Risérus, U, Berglund, L & Vessby, B (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129–1135.
Risérus, U, Smedman, A, Basu, S & Vessby, B (2004 a) Metabolic effects of conjugated linoleic acid in human subjects: the Swedish experience. Am J Clin Nutr 79, 1146S–1148S.
Risérus, U, Vessby, B, Ärnlöv, J & Basu, S (2004 b) Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80, 279–283.
Sethi, JK & Hotamisligil, GS (1999) The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10, 19–29.
Smedman, A & Vessby, B (2001) Conjugated linoleic acid supplementation in human subjects – metabolic effects. Lipids 36, 773–781.
Smedman, A, Vessby, B & Basu, S (2004) Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in human subjects: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond) 106, 67–73.
Turek, JJ, Li, Y, Schoenlein, IA, Allen, KGD & Watkins, BA (1998) Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6:n-3 fatty acid ratio. J Nutr Biochem 9, 258–266.
Van Lente, F (2000) Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 293, 31–52.
Yu, Y, Correll, PH, Vanden, Heuvel JP (2002) Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 1581, 89–99.
Zambell, KL, Keim, NL, Van Loan, MD, Gale, B, Benito, P, Kelley, DS & Nelson, GJ (2000) Conjugated linoleic acid supplementation in human subjects: effects on body composition and energy expenditure. Lipids 35, 777–782.